Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of re
CAS Number:
[2229047-91-8]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted